Purification engineering technology research center of Sichuan Province Natural Medicine
四川省天然藥物分離純化工程技術(shù)研究中心
文獻(xiàn)
S.-Y.Xu, Y.Luo, X.-F.Liu, et al. “UPLC-MS/MS-Network Pharmacology and Experimental Validation Reveal Active Components of Ficus tikoua for Ameliorating Liver Fibrosis.” Chemistry & Biodiversity23, no. 4 (2026): e71191
本文來自: 發(fā)布時(shí)間:2026-04-20
發(fā)表期刊:Chemistry & Biodiversity
發(fā)表時(shí)間:2026
Abstract:
Ficus tikoua is a medicinal plant traditionally used to treat jaundice and inflammatory-related diseases. However, the antihepatic fibrosis activity of F. tikoua and its active constituents remain unclear. In this study, a 75% ethanol extract of F. tikoua (FT-D12) was prepared and evaluated for antihepatic fibrosis effects using both in vitro and in vivo models. FT-D12 dose-dependently decreased the expression of fibrosis markers (FN, Collagen I, α-SMA). In mice, it significantly lowered serum levels of AST, ALT, HYP, hepatic levels of PC-III, COL IV, HA, and protein expression of α-SMA and FN. UPLC-MS/MS analysis elucidated 39 components in FT-D12, including 30 flavonoids. Network pharmacology screening highlighted apigenin-7-O-glucoside, quercetin, icariin, syringetin-3-O-glucoside, rutin, isorhamnetin-3-O-glucoside, and kievitone as potential antifibrotic candidates. Quercetin showed the strongest inhibitory effect on Collagen I and FN. Further investigation suggested its antifibrotic mechanism may involve modulation of the EGFR-AKT pathway. These findings provide insight into the anti-hepatic fibrosis properties of F. tikoua.
https://doi.org/10.1002/cbdv.71191

聯(lián)系我們
4000-369-963 028-85370565
18080489829@163.com
四川省 成都市 武侯區(qū) 武科西二路8號(hào)
關(guān)于普思
產(chǎn)品
技術(shù)服務(wù)

普思生物為您提供中藥化學(xué)對(duì)照品、高純化學(xué)試劑、天然產(chǎn)物化合物庫等優(yōu)質(zhì)產(chǎn)品,
僅用于科學(xué)研究、工業(yè)應(yīng)用等非醫(yī)療用途范疇,不可用于人的臨床治療或試驗(yàn),非藥用,非食用。
友情鏈接:全球化學(xué)品供應(yīng)商搜索 蓋德化工網(wǎng) 成都普思生物科技股份有限公司版權(quán)所有 蜀ICP備08100078號(hào)
咨詢
熱線
4000-369-963
7*24小時(shí)客服服務(wù)熱線
關(guān)注
微信
關(guān)注官方微信